The mononuclear phagocyte plays an important role in the regulation of microbe-induced inflammation, in part through its ability to secrete mediators, particularly cytokines, in response to microorganisms and their products. To evaluate the effects of the microbial flora associated with chronic adult periodontitis on cytokine induction, lipopolysaccharide (LPS) from the periodontopathogen Porphyromonas gingivalis was used to stimulate naive and phorbol ester-primed U937 monocytic cells, as well as elutriated human peripheral blood monocytes. We assessed the effect of this LPS, in comparison to that of LPS from Escherichia coli, on cell proliferation, cytokine induction, and surface expression of the LPS receptor CD14. P. gingivalis LPS stimulated proliferation of U937 cells at concentrations of greater than 1 ng/ml, while E. coli LPS inhibited proliferation. Phorbol myristic acid (PMA)-treated U937 cells and elutriated monocytes responded to E. coli LPS activation by producing tumor necrosis factor alpha (TNF-␣) mRNA and protein; however, P. gingivalis LPS induced greater numbers of TNF-␣ mRNA-positive cells and higher (P < 0.05) levels of protein than did E. coli LPS. Both cell types expressed interleukin-1 beta (IL-1␤) mRNA and protein in response to either LPS treatment. Compared with E. coli LPS, P. gingivalis LPS induced significantly (P < 0.05) higher numbers of IL-1 mRNA-positive U937 cells and elutriated monocytes, as well as production of significantly more (P < 0.05) IL-1 protein by the monocytes. The PMA-treated U937 cells and the monocytes produced high levels of IL-1 receptor antagonist mRNA and protein which were only marginally affected by the LPS preparations. While E. coli LPS induced expression of CD14 on the surface of PMA-primed U937 cells and monocytes, P. gingivalis LPS exhibited a significantly (P < 0.05) greater ability to enhance receptor levels. Our results indicate that P. gingivalis LPS can activate the mononuclear phagocyte for proliferation, cytokine production, and CD14 expression, providing evidence for the potential of this bacterial component to act as a critical regulatory factor in the chronic inflammatory response associated with periodontitis.
The mononuclear phagocyte is one of the principal cell types involved in the inflammatory response which occurs under conditions of chronic infection (40) . Periodontitis is an infectious process characterized by chronic inflammation affecting the supporting structures of the teeth. If left untreated, it may eventually lead to total destruction of the connective tissue and alveolar bone (39) . Specific gram-negative anaerobic bacteria, such as Porphyromonas gingivalis, have been suggested to play a primary role in the initiation and exacerbation of this condition (21) . Moreover, the host response to the periodontal microbial flora has been implicated in the pathology of periodontitis (27, 29) . The immune cells present in the periodontium, which could contribute to local host responses, include T, B, and phagocytic cells.
Lipopolysaccharide (LPS) is a major component of the outer membrane of gram-negative bacteria, including that of P. gingivalis (34) , and has the ability to activate host cells, especially mononuclear phagocytes (24) . This activation is mediated by the binding of LPS to cell surface receptors, e.g., the LPS receptor CD14 (18, 36) . Host responses can also be regulated by cytokines produced by several cell types in response to stimulation with LPS. In this regard, the macrophage plays an important role in regulating local inflammatory responses to bacterial insult by the production of cytokines, particularly proinflammatory interleukin-1 beta (IL-1␤) and tumor necrosis factor alpha (TNF-␣) and the anti-inflammatory IL-1 receptor antagonist (IL-1ra) (2, 8, 9) .
LPS from the periodontopathogen P. gingivalis differs biochemically from classical LPS derived from Escherichia coli (12) . The differences involve variations in phosphorylation and acylation patterns in the biologically active component, lipid A, and relative decreased toxicity of P. gingivalis LPS compared with E. coli LPS in lethal endotoxemia animal models (25, 28) . Furthermore, studies have shown that, in contrast to E. coli LPS, P. gingivalis LPS is capable of inducing some immune responses in the LPS-hyporesponsive C3H/HeJ inbred mouse strain (12, 20) . Mechanisms underlying the toxic and immunomodulating effects of Porphyromonas LPS in vivo are not well understood.
To determine the contribution of P. gingivalis LPS to chronic inflammatory periodontal disease, this study was aimed at testing the hypothesis that P. gingivalis LPS is functionally different from E. coli LPS in its ability to activate the mononuclear phagocyte. Therefore, we examined the effects of E. coli and P. gingivalis LPSs on proliferative responses, cytokine mRNA and protein induction, and LPS receptor expression in the U937 monocytic cell line and elutriated human peripheral blood monocytes. Our studies demonstrate that LPS from the periodontopathogen P. gingivalis, compared to E. coli LPS, displays an enhanced ability to induce monocyte proliferation and cytokine expression which may be related to increased expression of membrane CD14.
(This report was submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Microbiology in the Graduate School, The University of Alabama at Birmingham, Birmingham.)
MATERIALS AND METHODS
Reagents. LPS from P. gingivalis ATCC 33277 was prepared by hot phenol extraction (23) . LPS from E. coli K235 was prepared by phenol-water extraction (22) . No protein was detected in the LPS preparations by spectrophotometric methods, by silver staining of samples resolved in polyacrylamide gels, or by silver staining of samples electrophoretically resolved in a polyacrylamide gel, electroblotted onto a nitrocellulose membrane, and stained with a solution of colloidal gold (Enhanced Colloidal Gold Total Protein Detection Kit; Bio-Rad Laboratories, Hercules, Calif.). Stock solutions of LPS were prepared (1 mg/ml) in pyrogen-free, distilled H 2 O, boiled (15 min), and vortexed prior to use. Dulbecco modified Eagle medium (DMEM) and RPMI 1640 medium (Cellgro; Mediatech, Washington, D.C.), fetal calf serum (FCS; Hyclone Labs, Logan, Utah), phosphate-buffered saline (PBS; 9.25 mM Na 2 HPO 4 , 3.25 mM NaH 2 PO 4 ⅐ H 2 O, 145 mM NaCl), and elutriation components contained less than 0.3 ng of endotoxin per ml as measured by a chromogenic Limulus amebocyte lysate assay (Whittaker Bioproducts, Inc., Walkersville, Md.).
Preparation of U937 cells and elutriated monocytes. The well-characterized U937 cell line (35) was maintained at 37°C in an atmosphere of 5% CO 2 in air in 25-cm 2 tissue culture flasks (Falcon) by twice weekly splitting of cells 1:5 in RPMI medium containing 10% heat-inactivated FCS, 2 mM L-glutamine, 100 U of penicillin per ml, and 100 U of streptomycin per ml (complete RPMI medium). The cells were incubated with medium or 10 ng of phorbol myristic acid (PMA; Sigma, St. Louis, Mo.) per ml for 48 h to induce adherence and differentiation into macrophage-like cells (15, 31) . Following PMA treatment, the medium or the LPS was added and the cells were incubated for an additional 1 to 24 h.
Leukopacks containing peripheral blood mononuclear cells were obtained from healthy volunteers (from 24 to 38 years of age) by leukaphoresis. To isolate monocytes, the mononuclear cells were subjected to counterflow centrifugal elutriation (37, 38) . Briefly, the peripheral blood mononuclear cells were washed in PBS, pH 7.0, containing 100 g of DNase per ml, 250 g of gentamicin per ml, and 2 U of heparin per ml and then pumped at an initial flow rate of 10 ml/min into a spinning (500 ϫ g, 18°C) elutriation chamber (J-6M Elutriation Centrifuge; Beckman Instruments, Inc., Palo Alto, Calif.). The exciting cells were collected in 50-ml aliquots according to size distribution (Coulter Electronics, Hialeah, Fla.). The aliquots with a greater than 95% monocyte profile were pooled and counted. Monocytes (10 6 /ml) were cultured in 48-well tissue culture plates (500 l/well) or 25-cm 2 tissue culture flasks (5 ml/flask; Falcon; Becton Dickinson & Co., Lincoln Park, N.J.) in serum-free DMEM for 2 h at 37°C in 5% CO 2 in air. Following adherence of cells, an equal volume of DMEM supplemented with heat-inactivated FCS, glutamine, penicillin, and streptomycin was added to each culture to yield final supplement concentrations of 10% FCS, 2 mM L-glutamine, 100 U of penicillin per ml, and 100 U of streptomycin per ml (complete DMEM). The cells were kept in culture for 24 h prior to use in the experimental protocol.
Proliferation 6 cells per well in complete medium. Cultures were incubated (37°C, 5% CO 2 ) alone or with the indicated concentrations of the LPS preparations, and supernatants were collected at designated time points. Antigenic TNF-␣, IL-1␤, and IL-1ra were quantified by using an enzyme-linked immunosorbent assay (ELISA) as previously described (32) . Flat-bottom 96-well microtiter plates (Titertek; ICN Biomedicals, Inc., Horsham, Pa.) were coated with 100 l of goat anti-human TNF-␣ (1 g/ml), IL-1␤ (1 g/ml), or IL-1ra (3 g/ml) antibody (R&D Systems, Minneapolis, Minn.) in carbonate buffer (15 mM Na 2 CO 3 , 35 mM NaHCO 3 , 0.02% NaN 3 ) per well for 16 h at 4°C and then washed with PBS containing 0.05% Tween 20 (wash buffer). To block nonspecific binding sites, 5% heat-inactivated FCS in PBS was added to the wells and the plates were incubated for 2 h at room temperature. Supernatants (undiluted or diluted 1:4, 1:20, or 1:40) or cytokine standards (R&D Systems; see below) were added, and the mixtures were incubated for 16 h at 4°C. The plates were washed five times, 100 l of mouse monoclonal anti-human TNF-␣ (R&D Systems), IL-1␤ (R&D Systems), or IL-1ra (Bachem Bioscience, Inc., King of Prussia, Pa.) antibodies at 1 g/ml in 1% FCS-PBS was added per well, and the plates were incubated for 1 h at room temperature. The plates were washed five times, and 100 l of peroxidase-conjugated goat anti-mouse immunoglobulin G (Southern Biotechnology Associates, Inc., Birmingham, Ala.) diluted 1:4,000 in 1% FCS-PBS was added per well, and the plates were incubated for 1 h at room temperature. The plates were washed five times, and 100 l of chromogen ABTS substrate [0.25% 2,2Ј-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid); Sigma Chemical Co., St. ) was added to the wells. The plates were incubated at room temperature, and color development was read at 414 nm in a Vmax microplate reader (Molecular Devices Corp., Menlo Park, Calif.). Standards used in the assay were twofold dilutions of recombinant human TNF-␣ (1 ng/ml to 8 pg/ml), IL-1␤ (4 to 500 pg/ml), or IL-1ra (2 ng/ml to 16 pg/ml). The sensitivities of the ELISAs were 50, 15, and 50 pg/ml, respectively. Dilutions of supernatants giving optical density readings in the linear portion of the appropriate standard curve were used to quantitate the levels of each cytokine in the samples.
In situ hybridization. In situ hybridization was performed by a modification of previously described procedures (4, 17) . The probes used were antisense, singlestranded RNA molecules produced by transcription from a T7 or SP6 primer of a cDNA insert cloned into pBluescript (Stratagene, La Jolla, Calif.). The specific nucleotide sequences of the individual probes are as follows: TNF-␣, 344 to 917; IL-1␤, 445 to 1055; IL-1ra, 289 to 1102 (nucleotides numbered from the start of translation). The riboprobes were labeled with 0.35 mM digoxigenin-labeled UTP (Boehringer GmbH, Mannheim, Germany) and trace labeled with 0.01 mM [ 3 H]UTP (Amersham) with a known specific activity. A small sample of the purified probe was used to determine the amount of 3 H incorporated, from which the total amount of probe was calculated. Both sense and antisense probes were used at 400 pg/l/kb of probe complexity.
The stimulated U937 cells and elutriated monocytes were cultured as described above, in complete medium in 25-cm 2 flasks at 10 6 cells/ml. Following treatment, nonadherent cells were harvested by centrifugation at 400 ϫ g for 10 min at 4°C (non-PMA-treated U937 cells) and adherent cells were harvested by gentle scraping. Cytospin preparations of treated cells were fixed in 3% paraformaldehyde for 1 h, acetylated with 0.25% acetic anhydride-triethanolamine for 15 min, and prehybridized with a solution of 50% formamide, 1ϫ SSC (150 mM NaCl, 15 mM Na citrate), 1ϫ Denhardt's solution, 0.05% herring sperm DNA, 0.025% yeast tRNA, and 10% dextran sulfate for 1 h. The cells were incubated overnight at 50°C with 15 l of hybridization buffer containing a heatdenatured riboprobe for the cytokine of interest. The unhybridized riboprobe was removed by a 45-min incubation with 20 g of RNase A per ml in STE buffer (500 mM NaCl, 20 mM Tris-HCl, 1 mM EDTA) and high-stringency washing with 2ϫ SSC-50% formamide at 50°C (three times) and with 0.5ϫ SSC at 25°C (twice).
Cells positive for cytokine mRNA were detected with an alkaline phosphataseconjugated antidigoxigenin antibody (Boehringer GmbH) diluted 1:500 in 1% normal horse serum. The presence of antibody was detected by color development after the addition of a nitroblue tetrazolium substrate (Boehringer GmbH). Cells detected with digoxigenin-labeled RNA probes were quantitated with bright-field microscopy by direct counting. Five fields of positive and negative cells were counted at a magnification of ϫ10, and the values were expressed as the number of positive cells per 100 cells counted.
Flow cytometry analysis for CD14. Stimulated U937 cells and elutriated monocytes were cultured as described above and then characterized for the human LPS receptor CD14 by use of mouse monoclonal antibody MY4 (Coulter Clone, Hialeah, Fla.). The cells were harvested by gentle scraping and phenotypically characterized following incubation of aliquots of cell preparations with either fluorescein isothiocyanate-labeled MY4 or the immunoglobulin G2b isotypematched control (Coulter Clone). Analysis was performed with a FACStar (Becton Dickinson Immunocytometry Systems, San Jose, Calif.) fluorescence-activated cell sorter.
Statistical analysis. A comparison of the significance of the effects of LPS on cytokine and CD14 induction in U937 cells and monocytes was made with Student's t test and Fisher's PLSD statistical methods by using Statview 4.5 software (Abacus Concepts, Berkeley, Calif.) on a PowerMac 8500 computer (Apple Computer, Inc., Cupertino, Calif.).
RESULTS
Viability and proliferation. The U937 cell and elutriated monocyte preparations used in the studies were Ͼ90% viable in the presence or absence of LPS treatment as assessed by trypan blue exclusion. LPS-induced proliferation of U937 cells was dose dependent (Fig. 1) TNF-␣ production. In the absence of PMA differentiation, control U937 cells did not produce any detectable TNF-␣ (data not shown). Although detectable levels of TNF-␣ were present in supernatants of PMA-induced U937 cells, significantly (P Ͻ 0.05) larger amounts of TNF-␣ were released within 4 h after PMA-treated U937 cells were stimulated with either LPS preparation (Fig. 2) . P. gingivalis LPS stimulated the greatest release of TNF. Low doses of P. gingivalis LPS had very little effect on the PMA-differentiated U937 cells, while larger amounts of P. gingivalis LPS induced a dose-response induction of TNF-␣ (Fig. 3) . The ability of E. coli LPS to induce TNF-␣ production reached a plateau at a dose of 10 ng/ml.
The elutriated human monocytes stimulated with either LPS preparation produced significantly (P Ͻ 0.05) more TNF-␣ than did control cultures by 24 h (Fig. 4A ). Monocytes treated with 0.1 and 5 g of P. gingivalis LPS per ml produced significantly (P Ͻ 0.05) higher levels of TNF than did cells treated with the same concentrations of E. coli LPS.
IL-1␤ production. Undifferentiated U937 cells produced no detectable IL-1␤ following either LPS treatment, or the kinetics of IL-1␤ production by PMA-activated cells stimulated with LPS differed from that of TNF-␣ production. U937 cells treated with only PMA produced significantly more (P Ͻ 0.05) IL-1␤ than did control cultures (medium only) at 4 to 24 h (22 to 44 pg/ml versus less than 15 pg/ml). The addition of E. coli or P. gingivalis LPS to PMA-treated U937 cells increased the IL-1␤ levels in the supernatant in a dose-and time-dependent manner (27 to 142 pg/ml). E. coli LPS (100 ng/ml) stimulated a peak response at 12 h, whereas the same dose of P. gingivalis LPS stimulated a weaker response which peaked by 8 h. E. coli LPS (100 ng/ml) induced significantly (P Ͻ 0.05) more IL-1␤ (120 pg/ml) than the same dose of P. gingivalis LPS by 24 h (92 pg/ml). Higher concentrations of IL-1 were present in supernatants of cultures stimulated with 1 g P. gingivalis LPS per ml (150 pg/ml) than in cultures stimulated with a similar dose of E. coli LPS (110 pg/ml). The elutriated monocytes also responded to both LPS preparations (Fig. 4B) . By 24 h, supernatants from cultures of elutriated monocytes incubated with P. gingivalis LPS contained significantly (P Ͻ 0.05) more IL-1 than did those from cultures incubated with E. coli LPS.
IL-1ra production. The kinetics and dose response of U937 cells to LPS were characterized by the absence of IL-1ra without PMA priming and high levels of IL-1ra in the supernatant of cells treated with PMA alone (19,380 to 29,000 pg/ml). E. coli LPS at 1 g/ml was able to marginally increase IL-1ra levels in culture supernatants at 12 h. P. gingivalis LPS (0.1 g/ml) induced supernatant levels of IL-1ra consistently above levels in cells treated with PMA alone by 4 to 12 h (30,600 to 33,800 pg/ml). These levels returned to the baseline by 24 h. The induction of IL-1ra release by PMA-treated U937 cells stimulated with LPS was not dose dependent. The various doses of P. gingivalis LPS tested did not increase IL-1ra levels in the supernatant above those produced by treatment with PMA only (data not shown).
Unstimulated, elutriated monocytes produced relatively high levels of IL-1ra (Fig. 4C ). These cells were stimulated to release more IL-1ra after incubation with either LPS for 24 h. E. coli and P. gingivalis LPSs (100 ng/ml) induced significantly (P Ͻ 0.05) higher levels of IL-1ra than those seen in control cultures. At 5 g/ml, P. gingivalis LPS induced the production of IL-1ra levels which were significantly (P Ͻ 0.05) above the background and above the level produced following treatment with a similar dose of E. coli LPS.
Cytokine mRNA expression. Cytopreparations of U937 cells and monocytes were evaluated by in situ hybridization for cytokine mRNA. Neither P. gingivalis nor E. coli LPS stimulated detectable levels of mRNA for the cytokines in non-PMA-treated U937 cells ( Table 1 ). The PMA-treated U937 cell preparation contained cells with mRNAs for TNF-␣, IL-1␤, and IL-1ra. The proportion of PMA-treated cells expressing TNF-␣ and IL-1␤ mRNAs increased significantly (P Ͻ 0.05) after 4 h of incubation with LPS. PMA-treated cells stimulated with P. gingivalis LPS had more intense staining in a greater proportion of cells for both TNF-␣ and IL-1␤ mRNAs than did those stimulated with E. coli LPS (Fig. 5A) . Neither LPS preparation influenced the level of IL-1ra mRNA expression by U937 cells over treatment with PMA alone.
LPS treatment did not visibly alter the morphology of the adherent elutriated monocytes as assessed by use of Wright's stain (data not shown). Expression of mRNAs for TNF-␣, IL-1␤, and IL-1ra by elutriated monocytes was significantly (P Ͻ 0.05) enhanced by the LPS preparations over treatment with medium alone (Table 1 and The majority of the untreated, elutriated monocytes expressed CD14 on their surface, and the levels of expression were not affected by addition of either LPS (Fig. 6) . The initial surface expression of CD14 as assessed by MFI was significantly (P Ͻ 0.05) increased after stimulation of cells with E. coli or P. gingivalis LPS (100 ng/ml). Higher doses of E. coli and P. gingivalis LPS further enhanced the mean fluorescence on monocytes as assessed by use of a fluorescence-activated cell sorter.
DISCUSSION
The mononuclear phagocyte plays a critical role in the regulation of the host response during chronic inflammation (40) . The ability of microbial LPS to activate the monocytic cell to produce inflammatory cytokines may directly affect the outcome of bacterium-induced inflammation by promoting either an acute tissue reaction, resolution, or chronic destruction (3). The present study investigated whether P. gingivalis LPS differs from E. coli LPS in the ability to induce TNF-␣, IL-1␤, and IL-1ra production by monocytes, which would support its role in promoting chronic inflammatory activation and tissue destruction as characterized in periodontitis. The expression of the LPS receptor CD14 on the monocytes was also evaluated to determine its possible role in the activation process.
The LPS of the periodontopathogen P. gingivalis demonstrates chemical and biological differences from classical E. coli LPS (12, 25, 28) . P. gingivalis, in comparison to E. coli LPS, exhibits less endotoxic activity in vivo (25, 28) . It has also been shown that P. gingivalis LPS may be similar to E. coli LPS in terms of mitogenicity, polyclonal B-cell activation, stimulation of IL-1 production (20) , and the ability to induce TNF-␣ (33). However, other investigators have shown that P. gingivalis LPS, in contrast to E. coli LPS, does not induce epithelial cells to express E-selectin or promote neutrophil adhesion, which may facilitate bacterial colonization of the gingival tissue and persistence (7). Our results show that P. gingivalis LPS, compared to E. coli LPS, induced similar or higher levels of cytokine production by monocytes and that the higher cytokine expression related to upregulation of CD14 expression. Both U937 cells and human peripheral blood monocytes were used to evaluate cellular responses to the two LPS preparations. When the abilities of the LPS preparations to stimulate U937 cells were assessed, it was noted that at the higher concentrations of LPS tested, P. gingivalis LPS promoted cellular proliferation while a similar amount of E. coli LPS was inhibitory. This finding may be explained by a lesser toxicity of P. gingivalis LPS than E. coli LPS or by different mechanisms of cell activation. In gingival tissue, the initial proliferation of monocytic cells resulting from exposure to the LPS of the colonizing P. gingivalis could allow enhanced expression of inflammatory mediators in the region as the disease process progresses.
The U937 cells used in this study required PMA stimulation to become sensitive to LPS stimulation for a cytokine response, whereas the elutriated monocytes used were sensitized without pretreatment. This is likely due to the more advanced state of differentiation of the monocytes compared to the untreated cell line, particularly with regard to expression of LPS receptors (30) . Phorbol ester treatment of U937 cells induces them to differentiate into more macrophage-like cells (e.g., more extensive cytoplasm, increased protein synthesis, decreased mitosis, and increased HLA-DR and Fc-␥ receptor expression) (19, 26, 31, 35) . P. gingivalis LPS-stimulated release of TNF-␣ from both cell types was dose dependent at concentrations of 10 ng/ml to 1 g/ml. E. coli LPS stimulated maximum TNF-␣ release at a concentration of 10 ng/ml and did not promote greater TNF-␣ release at higher concentrations. These results extend the findings of others (33) showing the induction of similar levels of TNF-␣ by human peripheral blood monocytes stimulated with either E. coli or P. gingivalis LPS at Յ10 ng/ml. The ability of P. gingivalis LPS to stimulate TNF-␣ release at higher doses may allow the establishment of a chronic inflammatory process as the anaerobic P. gingivalis bacteria multiply in the diseased periodontal pocket. TNF-␣ released by the mononuclear phagocyte can target other inflammatory and accessory cells, as well as function as an autocrine activator. This response may lead to periodontal destruction via processes including neutrophil chemotaxis and degranulation, fibroblast production of collagenase, and osteoclast activation for bone resorption.
Unlike the TNF-␣ response, the IL-1␤ response to each LPS preparation was the same at all of the concentrations tested. This may reflect differences in the regulation of TNF and IL-1 responses to LPS, a finding that has been previously documented (5, 6) . The induction of these two cytokines appears to involve separate second-messenger systems which relay the LPS signal to the monocyte nucleus. The differences in TNF and IL-1 release which we observed in the LPS dose-response experiments might be explained by the separate routes of intracellular signaling which are used to activate mRNA transcription of the two cytokines. IL-1␤ may play a dual role in periodontal disease processes, as both a potent inducer of osteoclasts and an activator of B cells. It can therefore elicit both destruction of alveolar bone and protection from pathogenic flora colonization (10, 11, 16) .
In our studies, we observed high levels of IL-1ra which were 100 to 200 times those of IL-1␤. This amount of antagonist is required to effectively block the binding of IL-1 to its cellular receptor (14) . The inhibition of IL-1 activity can decrease inflammatory destructive processes and can dampen IL-1-associated immune activation (16) . IL-1ra production by the mononuclear phagocyte can function to protect tissues from an acute inflammatory response and may be involved in the healing phase of inflammation subsequent to periods of active destruction (1, 13) . However, it is not possible to discern from this study how LPS could influence a balance between IL-1 and IL-1ra production.
In situ hybridization experiments were performed to correlate cytokine mRNA induction with the observed protein expression following LPS stimulation of monocytic cells. Studies examining LPS cytokine induction in mononuclear phagocytes usually measure average quantities of cytokine mRNA induced in the entire population of cells. In this study, we utilized sensitive in situ hybridization methods to analyze the production of cytokine mRNAs by individual cells in the U937 and monocyte populations. Addition of PMA to the U937 cells caused expression of detectable levels of TNF-␣ mRNA, which were increased by E. coli LPS and further augmented by P. gingivalis LPS. Regulation of TNF-␣ protein release was associated with mRNA induction as observed by in situ hybridization. P. gingivalis LPS induced both TNF transcription and protein release. These findings are compatible with the potential role of P. gingivalis LPS in maintaining TNF-␣ expression in periodontal tissues and thereby promoting inflammation, release of prostaglandins and matrix metalloproteinases, osteoclast activation, and eventual bone loss.
Flow cytometric analyses demonstrated induction of CD14 expression in U937 cells (increased percentage of positive cells and increased MFI) and monocytes (increased MFI) caused by the addition of LPS, with P. gingivalis LPS eliciting a greater number of CD14-positive cells and higher MFIs than E. coli LPS. Increased expression of LPS receptors on the mononuclear phagocytes may account for their enhanced ability to produce TNF-␣ when treated with increasing doses of P. gingivalis LPS. This idea is supported by the finding that pretreatment of human monocytes with antibody to CD14 (MY4) resulted in a reduction of TNF-␣ mRNA and protein levels after LPS stimulation (33) . As more LPS receptors are avail- able on the cell surface, the cytokine response to the LPS may be further enhanced. In a periodontal lesion, the cells could respond to increasing levels of LPS and promote chronic activation.
Our studies have shown that there are differences in the manner of activation of mononuclear phagocytes by LPS from the periodontal pathogen P. gingivalis compared to E. coli LPS. This included differences in promotion of proliferation, cytokine mRNA and protein production, and expression of the LPS receptor CD14. The ability of P. gingivalis LPS to promote the expression of cytokines such as TNF-␣, IL-1␤, and IL-1ra and upregulation of CD14 expression may be important in the establishment of the chronically activated lesion with subsequent osseous tissue destruction observed in the inflammatory disease periodontitis. An understanding of the role of bacterial LPS in promoting cytokine production by monocytic cells at sites of inflammation will offer the opportunity to develop intervention strategies for the treatment of inflammatory diseases such as periodontitis.
